Form 4: Immunic Inc. Director Simona Skerjanec Receives Stock Options as Inducement Grant
SEC Form 4 Filing
Director Simona Skerjanec received stock options to purchase up to 150,000 shares of Immunic, Inc.'s common stock as an inducement grant related to her directorship appointment.
Summary
- Simona Skerjanec, a director of Immunic, Inc., received stock options as an inducement grant.
- The grant includes options to purchase up to 100,000 shares of Immunic's common stock, vesting monthly over three years, effective July 22, 2024.
- Additionally, Skerjanec received options to purchase up to 50,000 shares, vesting monthly over one year, also effective July 22, 2024.
- The exercise price for both stock option grants is $1.46.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The granting of stock options is a standard practice and indicates confidence in the director's contribution to the company's future success.
Positives
- The inducement grants of stock options to a director align her interests with those of the shareholders.
- The vesting schedules (three years and one year) encourage long-term commitment from the director.
Industry Context
Stock options are a common form of compensation for directors and executives, particularly in the biotech industry, to incentivize performance and align interests with shareholders. The size and vesting schedule of the options are typical for inducement grants.
Comparison to Industry Standards
- Stock option grants to directors are a standard practice in the biotechnology industry.
- Companies like Amgen, Gilead Sciences, and Biogen often use stock options as part of their compensation packages for board members.
- The vesting schedules (one and three years) are also typical, aligning with industry norms for incentivizing long-term commitment.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | NA | Simona Skerjanec | 07/22/2024 | Appointment as Director |
Stakeholder Impact
- Shareholders may view the stock option grants positively as they align the director's interests with the company's long-term success.
- Employees may see this as a positive sign of the company's commitment to attracting and retaining talent.
Key Dates
| Date | Description |
|---|---|
| 07/22/2024 | Date of earliest transaction, effective date of stock option grants, and start of vesting periods. |
| 07/24/2024 | Date of Form 4 filing. |
| 07/22/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.